3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
3
Sarcoma
3
Esophageal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Brain Neoplasms
3
Rhabdomyosarcoma
2
Prostatic Neoplasms
2
Osteosarcoma
2
Craniopharyngioma
2
Wilms Tumor
1
Vascular Neoplasms
1
Solitary Fibrous Tumors
1
Solid Tumor
1
Smooth Muscle Tumor
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Recurrent Head and Neck Carcinoma
1
Oligodendroglioma
1
Neurofibrosarcoma
1
Neuroblastoma
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Myoepithelioma
1
Mesothelioma, Malignant
1
Meningioma
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Hodgkin Disease
1
Interventions
talimogene laherparepvec
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Vorinostat
1
Taxes
1
Radiotherapy, Conformal
1
Paclitaxel
1
Mastectomy, Segmental
1
Mastectomy
1
Fulvestrant
1
Carboplatin
1
Brachytherapy
1
Anastrozole
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Ductal, Breast
×
Proton Therapy
×
90 days
×
Clear all
No trials found.